Výsledky vyhledávání - "Van Oijen, MGH"

No increased risk of hepatocellular carcinoma in cirrhosis due to Wilson disease during long-term follow-up

Autor: van der Meer, S, de Man, Rob, van den Berg, AP, Houwen, RHJ, Linn, FHH, van Oijen, MGH, Siersema, PD, van Erpecum, KJ

Publikováno v: Journal of Gastroenterology and Hepatology, 30(3), 535-539. Wiley-Blackwell Publishing Ltd

Background and AimsData on risk of hepatocellular carcinoma (HCC) in patients with Wilson disease are scarce. We determine HCC risk in a well-defined cohort of Wilson patients. MethodsAll patients with a confirmed diagnosis of Wilson disease (Leipzig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::2f57466eeff21802d4ecc797ab14239d
https://pure.eur.nl/en/publications/71aa7b29-a5c3-495a-bb55-fab9cc6f5919

Zobrazit plný text záznamu

Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk - Results from the EPIC cohort study

Publikováno v: International Journal of Cancer. 135(2)

Coffee and tea contain numerous antimutagenic and antioxidant components and high levels of caffeine that may protect against colorectal cancer (CRC). We investigated the association between coffee and tea consumption and CRC risk and studied potenti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1064::347d5cbd5b5e06d47e12865db2df0a2d
http://ora.ox.ac.uk/objects/uuid:70abd228-1bfa-4e63-9a95-a4ed8de435d5

Zobrazit plný text záznamu

The long-term outcome of patients with polycystic liver disease treated with lanreotide

Autor: Chrispijn, M, Nevens, F, Gevers, TJG, Vanslembrouck, R, van Oijen, MGH, Coudyzer, W, Hoffmann, AL (Aswin), Dekker, HM, de Man, Rob, van Keimpema, L, Drenth, JPH

Publikováno v: Alimentary Pharmacology & Therapeutics, 35, 266-74
Alimentary Pharmacology & Therapeutics, 35, 2, pp. 266-74
Alimentary Pharmacology & Therapeutics, 35(2), 266-274. Wiley-Blackwell Publishing Ltd

Item does not contain fulltext BACKGROUND: Polycystic liver disease (PLD) is a phenotypical expression of autosomal dominant polycystic kidney disease and isolated polycystic liver disease. Somatostatin analogues, such as lanreotide, reduce polycysti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e942dc38b56023501d7e162ff4970d04
http://hdl.handle.net/2066/109875

Zobrazit plný text záznamu

Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases

Autor: van Keimpema, L, de Koning, DB, van Hoek, B, van den Berg, AP (Aad), van Oijen, MGH, de Man, Rob, Nevens, F, Drenth, JPH

Publikováno v: Liver International, 31(1), 92-98. Wiley
Liver International, 31(1), 92-98. Wiley-Blackwell Publishing Ltd

Background and aim: Isolated polycystic liver disease (PCLD) is characterized by the presence of multiple cysts in the liver in the absence of polycystic kidneys. The clinical profile of PCLD is poorly defined and we set up a study for the clinical c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::189eb77b8e9562784ab67f23f7b4ce65
https://research.rug.nl/en/publications/d9dba3ba-8caf-4112-b7db-af015e997242

Zobrazit plný text záznamu

Current clinical care compared with new Dutch guidelines for hepatitis C treatment

Autor: Slavenburg, S, Lamers, MH, Roomer, Robert, de Knegt, Rob, van Oijen, MGH, Drenth, JPH

Publikováno v: Netherlands Journal of Medicine, 67(5), 177-181. Van Zuiden Communications

Background: Recently, the Dutch Association of Gastroenterology and Hepatology issued new guidelines for the treatment of chronic hepatitis C virus (HCV). These guidelines reflect the current standard of care. Before these guidelines were published a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::69bef34d727f4d698ebd8fdcf7b8a1dc
https://pure.eur.nl/en/publications/08b626d3-53cb-49d3-9e67-52bf73fc985b

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání